Best Stocks To Buy Now
Our list of the best stocks to buy now reflect the lesson of the past few years: Be ready for anything.
![gold, silver and bronze medals](https://cdn.mos.cms.futurecdn.net/gcvHYuBgWjkpCqwdgGccdC-415-80.jpg)
Kiplinger's annual investing outlook, which includes the best stocks to buy, has been a feature for our readers since 2012. As executive editor for Kiplinger's Personal Finance Magazine, I have authored the piece since then, surveying the stock market and economy and synthesizing my findings into key takeaways.
That's no small task, given the broad and dynamic nature of the market. Along with conducting plenty of research, I rely on my experience to draw out the most important trends and likely winners for the best stocks to buy in the coming year. I've covered this story for over a decade now, but I've been an investing writer for far longer. I've seen investors through a lot of bull and bear markets.
How you can choose the best stocks to buy
When gathering research for this year's article, I quickly encountered broad acknowledgement that the best line of defense for investors in the uncertain macroeconomic environment that we currently find ourselves in is being disciplined and selective when seeking out high-quality companies.
That means when investors are attempting to find the best stocks to buy now, they should look beyond factors such as company size (small-capitalization and large-capitalization stocks, for instance) or investing style (such as growth or value) and search for stocks of companies with consistent profits, good cash flow and other indicators that reflect quality.
"If a company generates more cash than it needs to run its business, it can do a number of useful things with it, such as pay dividends, buy back its stock, acquire other companies, expand its business and knock out its debts," writes Kiplinger contributor Will Ashworth on the importance of good cash flow.
And while Kiplinger's outlook provides context and advice related to general market trends, individual investors must consider their own risk tolerance and time horizon when deciding what works best for them and their own personal financial goals.
With that in mind, here are eight of the best stocks to buy now.
To continue reading this article
please register for free
This is different from signing in to your print subscription
Why am I seeing this? Find out more here
![Best stocks to buy](https://cdn.mos.cms.futurecdn.net/be2ukDhXJccgvVA7uu8BgA-415-80.jpg)
Best stocks to buy
To compile the list of the best stocks to buy, we looked for high-quality companies with solid fundamentals like strong earnings and revenue growth, as well as free cash flow, and many with a value tilt as measured by their forward price-to-earnings (P/E) ratios.
The names featured here vary by size and industry and are not meant to compose a diversified portfolio. But all, for one reason or another, are well positioned to benefit in an uncertain market environment.
Company | Ticker symbol |
---|---|
Coca-Cola | KO |
Cadence Design Systems | CDNS |
Diamondback Energy | FANG |
Thermo Fisher Scientific | TMO |
Delta Air Lines | DAL |
Pfizer | PFE |
Discover Financial Services | DFS |
Vulcan Materials | VMC |
![Coca-Cola](https://cdn.mos.cms.futurecdn.net/EYXHTq8RZJVEDZJvcVyLSK-415-80.jpg)
Coca-Cola
- Sector: Consumer staples
- Market value: $266.3 billion
- Dividend yield: 3.1%
Coca-Cola (KO) is a stronger company than it was at the start of the pandemic, after slimming its offerings by 600 products and moving away from sugary sodas with acquisitions such as coffee company Costa, says Argus Research analyst Taylor Conrad.
Coke beat analysts' top- and bottom-line expectations in the first quarter and raised its full-year guidance. Conrad expects steady growth for the remainder of this year and next.
Shares are a bargain as well, after underperforming the S&P 500 over the past year. Coke is one of the best dividend stocks too – it has raised its dividend for 62 consecutive years. At its current price, it boasts a 3.1% dividend yield.
![Cadence Design Systems](https://cdn.mos.cms.futurecdn.net/Wg7JYxNyFjsY7WiEX4tE9k-415-80.jpg)
Cadence Design Systems
- Sector: Technology
- Market value: $80.6 billion
- Dividend yield: N/A
Chip designs are increasingly complex, and that's driving demand for Cadence Design Systems' (CDNS) products, which help companies design and test semiconductors. Customers such as Nvidia (NVDA), Broadcom (AVGO) and Tesla (TSLA) can't stay away.
Cadence's sales related to artificial intelligence (AI) tripled in 2023, and analysts at Zacks Investment Research expect even faster growth in 2024. They predict earnings growth of 18% over each of the next three years, which is why CDNS is on this list of the best stocks to buy.
But the tech stock is pricey, so snap up shares on dips. Competition is stiff in the electronic design automation space – Cadence is number two – and that may create opportunities as firms jockey for market share in this fast-growing industry.
![Diamondback Energy](https://cdn.mos.cms.futurecdn.net/ozBtG54a5Mx5CAm7Vz2L6b-415-80.jpg)
Diamondback Energy
- Sector: Energy
- Market value: $35.3 billion
- Dividend yield: 4.7%
Diamondback Energy (FANG), with a market value of more than $35 billion, is the premier pure-play shale driller in the Southwest's Permian Basin, according to analysts at The Carson Group, an investment management firm. Diamondback has an exceptionally low cost of production, they note, and generates attractive free cash flow – a key factor for those seeking out the best stocks to buy.
"If you're bullish on oil prices, which we are, then Diamondback is a good bet," they say.
Income-oriented investors will appreciate Diamondback's juicy 4.7% yield. And the shares trade at just 10.2 times the consensus of analysts' expected earnings for the next 12 months. The consensus price target for Diamondback's shares is an average $222.04, which implies a gain of more than 12% from the energy stock's recent close.
![Thermo Fisher Scientific](https://cdn.mos.cms.futurecdn.net/k3DF8dmFtkCZa2Ua4nsW6H-415-80.jpg)
Thermo Fisher Scientific
- Sector: Healthcare
- Market value: $218.6 billion
- Dividend yield: 0.3%
Scientific research may ramp up this year, and that is promising for Thermo Fisher Scientific (TMO), which makes equipment that researchers need to do their jobs. The turnaround may take time, but patient investors could find that Thermo Fisher is one of the best stocks to buy for 2024 and beyond.
The company's solid execution record is a plus, says R.W. Baird analyst Catherine Ramsey Schulte, who rates the stock Outperform, the equivalent of a Buy. A diverse array of customers, including biopharma firms, hospitals, diagnostic labs, universities and research institutions, among others, helps. Some of those end markets have been improving recently.
![Delta Air Lines](https://cdn.mos.cms.futurecdn.net/Z6xy8NvFwZPaLWjCzacqGF-415-80.jpg)
Delta Air Lines
- Sector: Industrials
- Market value: $32.5 billion
- Dividend yield: 0.8%
Despite turbulence elsewhere in the travel industry, Delta Air Lines (DAL) is on a smooth course, with the seatbelt sign switched off for investors, according to analysts at Morgan Stanley, where Delta is a top pick.
Delta should generate per-share earnings of $7-plus in 2024 and more than $10 per share beyond, "which is still not close to being priced into the stock," they say. Domestic flights are "holding up" while corporate and international travel remain "robust."
Morgan Stanley analysts believe Delta's management has been conservative in its guidance about fuel costs but acknowledge potential volatility there. Still, the analysts see the stock soaring to a 12- to 18-month price target of $85 a share – nearly 70% above its current price. This potential upside makes DAL one of the best stocks to buy.
![Pfizer](https://cdn.mos.cms.futurecdn.net/RSCfPYApUNUL7xTbMpCyY-415-80.jpg)
Pfizer
- Sector: Healthcare
- Market value: $160.4 billion
- Dividend yield: 5.9%
Jefferies analysts say they're being contrarian with their buy call on Pfizer (PFE). Shares of the pharmaceutical giant are down 26% in the past 12 months, largely due to waning demand for COVID-related products.
But the bulls at Jefferies see several catalysts for better days, including a $3.5 billion cost-cutting program that will make earnings targets more achievable. Jefferies sees earnings of $2.21 a share in 2024 and $2.75 in 2025.
Other potential bright spots include the firm's oral obesity drug, currently in clinical trials. If viable, it has annual sales potential of $4 billion, according to Jefferies. The firm's price target for the healthcare stock is $32, implying a 13% gain.
![Discover Financial Services](https://cdn.mos.cms.futurecdn.net/NUHRFEuPTtdXM58EPzCE3X-415-80.jpg)
Discover Financial Services
- Sector: Financial services
- Market value: $30.5 billion
- Dividend yield: 2.3%
Stock in Discover Financial Services (DFS) trades at a discount to its fair value, says Morningstar analyst Michael Miller. However, this spread was narrowed after Capital One (COF) in February said it plans to buy the credit card company in an all-stock deal worth $35 billion, news that sent DFS shares soaring.
About 70% of Discover's revenue is interest income from its credit cards – a plus if interest rates remain high. He adds that Discover's credit card business has historically generated better results than most of its peers.
If economic wobbles mean consumers spend less – or worse, fail to make their card payments – that's a worry. But Discover is financially strong; Morningstar gives it an "A" for financial health, good news for investors looking for the best stocks to buy. Analysts expect flat earnings growth through 2024 compared with 2023, but they see a 26% jump in 2025, which bodes well for the financial stock.
As for the potential buyout by Capital One, Miller is neutral on the deal. While the analyst sees the strategic value for it and believes COF is paying a fair price, he notes that "there will be meaningful integration risk, and some uncertainty surrounds regulatory approval, as the combined company would be the largest credit card issuer in the United States by loan volume."
![Vulcan Materials](https://cdn.mos.cms.futurecdn.net/3cNmVUnzUkvNBHCxBNNjpc-415-80.jpg)
Vulcan Materials
- Sector: Basic materials
- Market value: $33.6 billion
- Dividend yield: 0.7%
Vulcan Materials (VMC) is the largest U.S. producer of construction aggregates – think crushed stone, sand and gravel. It's also a major producer of asphalt and concrete. The company faces challenges in its residential housing construction business, but that's offset by momentum in highways and other public infrastructure.
"We remain intrigued by the generational increase in funding" for projects driven by the Infrastructure Investment and Jobs Act of 2021, write analysts at investment firm Raymond James.
Vulcan isn't cheap, trading at 28 times earnings estimates from a consensus of analysts. But a Street-high price target of $322 implies the materials stock could rally another 27% from recent levels, adding to its already impressive 30% year-over-year total return (price change + dividends).
Note: The original version of this article first appeared in Kiplinger's Personal Finance Magazine, a monthly, trustworthy source of advice and guidance, though it has since been updated. Subscribe to help you make more money and keep more of the money you make here.
Related content
Anne Kates Smith brings Wall Street to Main Street, with decades of experience covering investments and personal finance for real people trying to navigate fast-changing markets, preserve financial security or plan for the future. She oversees the magazine's investing coverage, authors Kiplinger’s biannual stock-market outlooks and writes the "Your Mind and Your Money" column, a take on behavioral finance and how investors can get out of their own way. Smith began her journalism career as a writer and columnist for USA Today. Prior to joining Kiplinger, she was a senior editor at U.S. News & World Report and a contributing columnist for TheStreet. Smith is a graduate of St. John's College in Annapolis, Md., the third-oldest college in America.
- Nellie S. HuangSenior Associate Editor, Kiplinger's Personal Finance
- Lisa GerstnerEditor, Kiplinger Personal Finance magazine
-
Stock Market Today: Stocks Give Up Gains Even as Inflation Ebbs
The main indexes closed lower Friday but ended the first half with impressive gains.
By Karee Venema Published
-
Best Places to Rent 2024 — How Does Your City Rank?
The best places to rent in the U.S. include Miami, suburban Chicago and North Jersey, according to a new survey from RentCafe.
By Kathryn Pomroy Published
-
Stock Market Today: Stocks Give Up Gains Even as Inflation Ebbs
The main indexes closed lower Friday but ended the first half with impressive gains.
By Karee Venema Published
-
Nokia to Acquire Infinera in $2.3 Billion Deal: What to Know
Nokia will acquire Infinera as it looks to expand its optical-networking presence. Here's what you need to know.
By Joey Solitro Published
-
Trump Media & Technology Stock Stays Volatile After Debate
Trump Media & Technology stock has traded erratically in recent months and last night's presidential debate sparked more volatility in DJT shares.
By Joey Solitro Published
-
Nike Stock Sinks on Dismal Sales Forecast: What to Know
Nike stock is spiraling Friday after the athletic and apparel retailer missed sales estimates for its most recent quarter and lowered its outlook for its new fiscal year.
By Joey Solitro Published
-
Stock Market Today: Stocks End Higher Ahead of May PCE Data
Micron Technology, Walgreens Boots Alliance and Levi's were three of Thursday's biggest movers.
By Karee Venema Published
-
How to Find the Best Small-Cap Stocks to Buy
Wall Street's best small-cap stocks to buy include biotech, real estate and industrials names.
By Dan Burrows Published
-
Levi Strauss Stock Spirals on Revenue Miss: What to Know
Levi Strauss stock is lower Thursday after the denim company's top line missed estimates amid a "cautious" consumer environment.
By Joey Solitro Published
-
Walgreens Stock Hits 27-Year Low After Massive Earnings Miss
Walgreens Boots Alliance stock is tanking Thursday the pharmacy retailer came up short of earnings expectations and slashed its full-year outlook. Here's what you need to know.
By Joey Solitro Published